/
Other
Liver Transplant
68
Pipeline Programs↗
42
Active Trials↗
47
Companies Involved↗
Liver Transplant is a moderately active landscape with 68 programs across 47 companies. The most active players are Gilead. 8 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical54
Phase 25
Phase 38
Approved
No programs
Analysis
Modality Breakdown
87%
Small molecule
53 of 61 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 61 classified programs, each share of the total. Modality classified for 100% of 68 pipeline programs.
Analysis
Trial Status
374
clinical trials
Completed191 · 51%
Unknown status85 · 23%
Terminated37 · 10%
Withdrawn19 · 5%
Recruiting17 · 5%
Not yet recruiting14 · 4%
Other11 · 3%
Clinical Trials
Trial Activity
374 trials
EVR and EPO for Liver Transplant Tolerance
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT06832189·20 enrolled
Page 1 of 25
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)